Patients with prosthetic heart valves who present with symptoms of heart failure or hemolytic anemia may suffer from paravalvular regurgitation, also known as paravalvular leak (PVL).
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Traditionally, PVL has been repaired with repeat open-heart surgery, which can pose greater risk than a first time operation and carries a risk of recurrent PVL. In recent years, experienced interventional cardiologists have achieved excellent results with percutaneous closure of PVL. Outcomes at Cleveland Clinic and other well-equipped centers suggest that this structural intervention has a promising future.
Essentials of PVL
PVL is the result of a space between the native cardiac tissue and the prosthetic valve. It occurs in about 2 to 12 percent of patients with bioprosthetic or mechanical valves, and more often in the mitral than the aortic position. PVL in the tricuspid position is rarer still, but it can occur.
Risk factors for developing PVL include (among others) multiple valve replacements in the same position, severe calcification of the valve annulus and surgery for endocarditis.
How PVL is detected
Recognition of PVL usually starts with suspicion arising from the clinical history. The diagnosis is then made by echocardiography. Often, transthoracic echocardiography is limited by “shadowing” around a prosthetic valve, and transesophageal echocardiography (TEE) must be performed to confirm the diagnosis.
Advanced imaging is critical to planning and performing the procedure. Operators may be guided by 2-D and 3-D TEE, intracardiac echocardiography, fluoroscopy/angiography and, recently, combined CT and fluoroscopy.
The procedure: a bit like plugging a bottle with cotton
Leaks are repaired by placing one or more nitinol plugs in the defect, much like stuffing a cotton ball in the top of a medicine bottle. There are currently no devices specifically designed to treat PVL. Instead, operators use one or another vascular or septal occluder based on the leak’s size and shape. Choice of device is guided by preprocedural imaging and intraprocedural monitoring.
Percutaneous closure of a paravalvular mitral leak is performed one of three typical ways:
- Most often, catheters are placed via the femoral vein and introduced to the left atrium through a transseptal puncture, after which wires are advanced across the leak. Over these wires, delivery catheters are advanced to place the closure devices.
- In some cases, catheters are placed via the femoral artery.
- The third method is to place a catheter directly into the left ventricular apex percutaneously through the chest wall (with no incision).
Aortic valve procedures are generally done via the femoral artery.
Aside from procedures for which apical access is necessary, percutaneous PVL closure at Cleveland Clinic is performed using local anesthesia and conscious sedation, not general anesthesia, and without endotracheal intubation.
Safe and efficacious in experienced hands
Small reports and large series have been published over the past 20 years showing that percutaneous PVL closure is safe and efficacious. Most patients enjoy freedom from significant heart failure symptoms, blood transfusions due to hemolysis or need for repeat open-heart surgery.
The procedure requires a highly skilled and experienced team of interventional cardiologists, imaging cardiologists, and catheterization lab technicians and nurses with access to specialized equipment and advanced imaging modalities.
Performed carefully, percutaneous PVL closure provides an effective but less-invasive alternative to repeat open-heart surgery for a number of patients suffering from this condition.